Filing Details

Accession Number:
0001181431-12-016007
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-09 15:52:56
Reporting Period:
2012-03-07
Filing Date:
2012-03-09
Accepted Time:
2012-03-09 15:52:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178879 Amicus Therapeutics Inc FOLD Pharmaceutical Preparations (2834) 200422823
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1005544 Iii W Charles Newhall 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-07 214,846 $5.70 1,066,029 No 4 P Indirect See Note 2
Common Stock Acquisiton 2012-03-07 925,154 $5.70 4,584,311 No 4 P Indirect See Note 4
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Note 2
No 4 P Indirect See Note 4
Footnotes
  1. On March 7, 2012, New Enterprise Associates 9, Limited Partnership ("NEA 9"), purchased 214,846 shares of Common Stock in the Issuer's registered underwritten public offering at the price to the public of $5.70 per share.
  2. The Reporting Person is a general partner of NEA Partners 9, Limited Partnership, the sole general partner of NEA 9, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 9 shares in which the Reporting Person has no pecuniary interest.
  3. On March 7, 2012, New Enterprise Associates 11, Limited Partnership ("NEA 11"), purchased 925,154 shares of Common Stock in the Issuer's registered underwritten public offering at the price to the public of $5.70 per share.
  4. The Reporting Person is an individual manager of NEA 11 GP, LLC, the sole general partner of NEA Partners 11, Limited Partnership ("NEA Partners 11"). NEA Partners 11 is the sole general partner of NEA 11, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 11 securities in which the Reporting Person has no pecuniary interest.